Literature DB >> 28804148

Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy.

David R Hager1, Rosemary A Persaud2, Ryan W Naseman3, Kavish Choudhary4, Kristen E Carter5, Amanda Hansen6.   

Abstract

Background: While hospital beds continue to decline as patients previously treated as inpatients are stabilized in ambulatory settings, the number of critical care beds available in the United States continues to rise. Growth in pharmacy student graduation, postgraduate year 2 critical care (PGY2 CC) residency programs, and positions has also increased. There is a perception that the critical care trained pharmacist market is saturated, yet this has not been evaluated since the rise in pharmacy graduates and residency programs. Purpose: To describe the current perception of critical care residency program directors (CC RPDs) and directors of pharmacy (DOPs) on the critical care pharmacist job market and to evaluate critical care postresidency placement and anticipated changes in PGY2 CC programs.
Methods: Two electronic surveys were distributed from October 2015 to November 2015 through Vizient/University HealthSystem Consortium, American Society of Health-System Pharmacists (ASHP), Society of Critical Care Medicine, and American College of Clinical Pharmacy listservs to target 2 groups of respondents: CC RPDs and DOPs. Questions were based on the ASHP Pharmacy Forecast and the Pharmacy Workforce Center's Aggregate Demand Index and were intended to identify perceptions of the critical care market of the 2 groups.
Results: Of 116 CC RPDs, there were 66 respondents (56.9% response rate). Respondents have observed an increase in applicants; however, they do not anticipate increasing the number of positions in the next 5 years. The overall perception is that there is a balance in supply and demand in the critical care trained pharmacist market. A total of 82 DOPs responded to the survey. Turnover of critical care pharmacists within respondent organizations is expected to be low. Although a majority of DOPs plan to expand residency training positions, only 9% expect to increase positions in critical care PGY2 training. Overall, DOP respondents indicated a balance of supply and demand in the critical care trained pharmacist market. In comparing RPD and DOP perceptions of the demand for critical care pharmacists, DOPs perceived demand to be higher than RPDs (mean, 3.2 vs 2.8; P = .032).
Conclusion: Although there is a perception of the oversupply of critical care trained pharmacists, a survey of DOPs and CC RPDs found a market with positions available, rapid hiring, stable salaries, and plans for expanded hiring of critical care trained pharmacists.

Entities:  

Keywords:  critical care; employment; pharmacists; pharmacy; pharmacy residencies; students; surveys

Year:  2017        PMID: 28804148      PMCID: PMC5551640          DOI: 10.1177/0018578717715352

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  8 in total

1.  Critical care pharmacy services in United States hospitals.

Authors:  Robert Maclaren; John W Devlin; Steven J Martin; Joseph F Dasta; Maria I Rudis; C A Bond
Journal:  Ann Pharmacother       Date:  2006-03-28       Impact factor: 3.154

2.  Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.

Authors:  Brian L Erstad; Curtis E Haas; Terence O'Keeffe; Cheryl A Hokula; Kathleen Parrinello; Andreas A Theodorou
Journal:  Pharmacotherapy       Date:  2011-02       Impact factor: 4.705

3.  National survey of critical-care pharmaceutical services.

Authors:  J F Dasta; R Segal; A Cunningham
Journal:  Am J Hosp Pharm       Date:  1989-11

4.  Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions.

Authors:  Robert MacLaren; R Brett McQueen; Jon Campbell
Journal:  Pharmacotherapy       Date:  2013-03-06       Impact factor: 4.705

5.  Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections.

Authors:  Robert MacLaren; C A Bond; Steven J Martin; David Fike
Journal:  Crit Care Med       Date:  2008-12       Impact factor: 7.598

Review 6.  Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care.

Authors:  Marilyn T Haupt; Carolyn E Bekes; Richard J Brilli; Linda C Carl; Anthony W Gray; Michael S Jastremski; Douglas F Naylor; Maria Rudis PharmD; Antoinette Spevetz Md; Suzanne K Wedel; Mathilda Horst Md
Journal:  Crit Care Med       Date:  2003-11       Impact factor: 7.598

Review 7.  Pharmacist contributions as members of the multidisciplinary ICU team.

Authors:  Candice R Preslaski; Ishaq Lat; Robert MacLaren; Jason Poston
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

8.  Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.

Authors:  Robert MacLaren; C A Bond
Journal:  Pharmacotherapy       Date:  2009-07       Impact factor: 4.705

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.